| Video
Too often, prescribers are the last to learn of an overdose event and worse, fail to take action once notified. Attorney Bolen outlines policies and protocols that practitioners can implement to proactively signal their intent to get things right when they go wrong.
| Article
A case report authored by an investigative team from West Virginia University has uncovered a new risk associated with the use of the synthetic narcotic fentanyl: it may produce a distinctive form of amnesia. The extreme potency of fentanyl, at between 50 to 100 times greater than morphine, also...
| Article
The risk for opioid dependency among opioid-naïve cancer patients who took the medication following lung surgery, is highlighted in new research presented earlier this week at the annual meeting of The Society of Thoracic Surgeons. Lead author Alexander Brescia, MD, commented, “Surgeons are at the...
| Article
Results of a study conducted by researchers from Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, suggest that a new patient education brochure is effective in forestalling diversion of opioid medications. The patient education material outlines safe medication...
| Article
A study conducted by researchers at the Centers for Disease Control and Prevention sheds new light on national patterns for opioid prescribing to US patients who are below age 65 and on disability. The survey included data from 2014 on some 3.5 million Medicare Part D recipients who were medically...
| Article
A new study, led by RTI International, will examine fresh strategies that may be effective in addressing the crisis of opioid misuse while preserving access to opioids for chronic pain patients who benefit from their use. Lead researcher Lauren McCormack, PhD, vice president of the Public Health...
| Video
Gabapentin and pregabalin are being misused and abused, but remain unscheduled. Why? What's all the GABA about? Drs. Brooks and Kominek discuss.
| Article
Medication assisted therapy (MAT) has been shown to be an effective approach to treating patients with substance abuse issues, but its implementation by primary care has been slow and uneven. New research conducted by a team from University of Michigan seeks to address this problem and encourage the...
| Video
Jeremy A. Adler, MS, PA-C, of Pacific Pain Medicine Consultants, emphasizes the importance of the patient/practitioner conversation about the importance of drug safety. Communication and safety are key.
| Video
In addition to other shortcomings, current prescribing guidelines are particularly ill-suited to the needs and challenges of patients already on opioid therapy. Drs. Heit and Gourlay discuss the roots of the problem and the role of primary care as talented amateurs in addiction medicine.